1-248038589-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001385855.1(OR2L2):c.322G>A(p.Val108Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000409 in 1,614,066 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001385855.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR2L2 | NM_001385855.1 | c.322G>A | p.Val108Ile | missense_variant | 3/3 | ENST00000641771.1 | |
OR2L2 | NM_001004686.3 | c.322G>A | p.Val108Ile | missense_variant | 2/2 | ||
OR2L13 | NM_001304535.3 | c.-18-60769G>A | intron_variant | ||||
OR2L13 | NM_175911.5 | c.-143-60062G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR2L2 | ENST00000641771.1 | c.322G>A | p.Val108Ile | missense_variant | 3/3 | NM_001385855.1 | P1 | ||
OR2L2 | ENST00000366479.4 | c.322G>A | p.Val108Ile | missense_variant | 1/1 | P1 | |||
OR2L2 | ENST00000642011.1 | c.322G>A | p.Val108Ile | missense_variant | 2/2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152194Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000477 AC: 12AN: 251446Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135890
GnomAD4 exome AF: 0.0000431 AC: 63AN: 1461872Hom.: 0 Cov.: 31 AF XY: 0.0000578 AC XY: 42AN XY: 727238
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152194Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74366
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 29, 2022 | The c.322G>A (p.V108I) alteration is located in exon 1 (coding exon 1) of the OR2L2 gene. This alteration results from a G to A substitution at nucleotide position 322, causing the valine (V) at amino acid position 108 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at